This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Lawrence Livermore National Security, LLC, Amplyx Pharmaceuticals, Inc.. Active years: 2014-2024.
Company Filing History:
6 out of 2,405 
4 out of 1,624 
1 out of 3 Years Active: 2014-2024
Title: Michael Trzoss: Innovator in Antifungal Agents
Introduction
Michael Trzoss is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal agents. With a total of nine patents to his name, Trzoss has established himself as a key figure in innovation.
Latest Patents
Among his latest patents are the "Heterocycle Substituted Pyridine Derivative Antifungal Agents." These patents describe compounds and pharmaceutical compositions that are effective in treating fungal diseases and infections. The innovative nature of these compounds highlights Trzoss's commitment to advancing medical science.
Career Highlights
Throughout his career, Michael Trzoss has worked with prominent organizations such as Merck Sharp & Dohme Corporation and Lawrence Livermore National Security, LLC. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Trzoss has collaborated with talented individuals in his field, including Zhiyong Chen and Thanh To Lam. These partnerships have further enhanced his work and led to the development of impactful innovations.
Conclusion
Michael Trzoss is a distinguished inventor whose work in antifungal agents has made a significant impact on the pharmaceutical industry. His dedication to innovation and collaboration continues to drive advancements in medical treatments.